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PEMANTAUAN KEBERKESANAN DALAM PENYINGKIRAN KEHADIRAN 
SURIH AOZ (DERIVATIF FURAZOLIDON) YANG TERDAPAT DALAM 
PENAEUS MONODON DAN PRODUKNYA MELALUI PROSES YANG 
BERBEZA-BEZA 
 
ABSTRAK 
 
 
Pihak berkuasa Malaysia telah mengharamkan penggunaan furazolidon (salah satu 
daripada nitrofuran utama yang ada) dalam haiwan ternakan. Hal ini adalah 
berdasarkan risiko dari segi kesihatan yang boleh memudaratkan orang umum. 
Penekanan diberi dalam mengesan kehadiran metabolit utama furazolidon, iaitu 3-
amino-2-oxazolidinona (AOZ). Metabolit ini adalah lebih stabil dan kekal lebih lama di 
dalam tisu haiwan berbanding dengan furazolidon. Oleh itu, pengesanan metabolit 
merupakan kaedah paling sesuai dalam penilaian tentang penyalahgunaan 
furazolidon. Kaedah pengesahan melibatkan penggunaan pengionan elektrosembur 
positif kromatografi cecair-spektrometri jisim tandem (ESI LC-MS/MS) untuk menentu 
paras AOZ dalam udang harimau (Penaeus monodon). Sebelum analisis LC-MS/MS 
dijalankan, sampel akan melalui pelbagai peringkat penyediaan, termasuk 
penghomogenan, hidrolisis asid metabolit yang terangkai pada protein, dan 
derivatasasi dengan 2-nitrobenzaldehid (2-NBA). Pembersihan sampel dan penulenan 
analit dijalankan dengan melibatkan pengekstrakan berganda dengan etil asetat. 
Pemisahan molekul dijalankan dengan menggunakan kromatografi cecair dengan 
kolum C18 (Inertsil
!
 ODS-3 50.0 mm x 2.1 mm, 3 µm) pada suhu bilik. Kuantifikasi 
analit dijalankan berdasarkan garis panduan daripada EU dengan melibatkan 
pemantauan tindakbalas selektif (SRM) yang melibatkan satu ion prekursor dan dua 
ion produk sebagai penentu. Kuantifikasi yang lebih jitu dan sensitif diperoleh melalui 
penggunaan standard terdeturasi (AOZ-d4) sebagai standard dalaman (IS). Kaedah 
yang digunakan divalidasi berdasarkan garis panduan daripada Commission Decision 
2002/657/EC dengan melibatkan penggunaan sampel blank dan standard matrik 
(ditambah dengan AOZ ataupun 2-NPAOZ, bersama-sama dengan AOZ-d4). Validasi 
 xvii 
dijalankan terhadap spesifisiti analit, identifikasi molekular (termasuk RRT, titik 
pengesahan, nisbah S/N, dan nisbah ion transisi), kelinearan, pengekstrakan 
perolehan, persisi (termasuk kebolehulangan, dan kebolehulangan intra-makmal), dan 
had analitikal (termasuk LOD, LOQ, CC", and CC#) untuk menentukan kesuaian 
keadah ini. Had analitikal untuk semua matrik udang berada di bawah paras MRPL 
untuk nitrofuran (1 ng/g). Kurva piawai berada dalam bentuk linear untuk julat 
kepekatan AOZ dari 0 hingga 2,000 ng/g untuk semua matrik udang. Udang harimau 
dirawat dengan furazolidon melalui kaedah rawatan mandi dengan kepekatan 30 mg 
furazolidon/L air garam untuk 10 hari berturut-turut. Residu AOZ dalam otot, kepala 
dan eksoskeleton udang mencapai paras maksimum, iaitu pada kepekatan 8,671.08 ± 
628.80 ng/g, 9820.14 ± 4,15.47 ng/g, and 11,025.12 ± 730.76 ng/g, masing-masing 
sebaik sahaja selepas rawatan furazolidone. AOZ adalah sangat susah untuk 
disingkirkan. Oleh demikian, AOZ masih boleh dikesan selepas 2 bulan dari rawatan 
terakhir. Tiga jenis produk udang dipilih, iaitu udang beku tanpa kulit, urat and kepala, 
udang masak beku tanpa kulit, urat and kepala, dan udang jeruk. Proses yang terlibat 
dalam penghasilan produk-produk yang terpilih tidak berjaya dalam menyingkirkan 
kesemua residu AOZ dalam udang yang dirawat dengan furazolidon. Penyingkiran 
AOZ yang terbanyak boleh diperoleh melalui proses yang terlibat dalam penyediaan 
udang masak beku tanpa kulit, urat dan kepala yang melibatkan penggunaan 1 % asid 
laktik, iaitu sedikit kurang daripada 50 % (termasuk peratusan penyingkiran daripada 
pra-pemprosesan).  
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MONITORING THE EFFECTIVENESS IN ELIMINATING THE TRACE 
PRESENCE OF AOZ (FURAZOLIDONE DERIVATIVE) RESIDUE IN 
PENAEUS MONODON AND ITS PRODUCTS UNDERGOING DIFFERENT 
PROCESSING REGIMES 
 
ABSTRACT 
 
 
Due to its risk showered upon public health, Malaysia authorities has prohibited the use 
of furazolidone (one of the main nitrofurans available), in food-producing animals. 
Monitoring compliance with the ban has focused on the detection of its main 
metabolite, 3-amino-2-oxazolidinone (AOZ), which is more stable and persists in the 
animal tissues with comparison to the parent compound. Thus it’s the best approach to 
evaluate their utilization. A confirmatory method based on positive electrospray 
ionization liquid chromatography-tandem mass spectrometry (ESI LC-MS/MS) has 
been utilised for the trace level determination of AOZ in tiger prawns (Penaeus 
monodon). Prior to LC-MS/MS analysis, samples undergo various preparation, which 
entails homogenisation, acid hydrolysis of the protein-bound metabolites and 
derivatisation with 2-nitrobenzaldehyde (2-NBA). Sample clean-up and analyte 
enrichment was performed by a double liquid-liquid extraction with ethyl acetate. 
Separation of the molecules was performed by liquid chromatography in a C18 column 
(Inertsil
!
 ODS-3 50.0 mm x 2.1 mm, 3 µm) at room temperature. Analyte quantification 
was performed according to EU guidelines, using selective reaction monitoring (SRM) 
with one precursor ion and two product ions as identifiers. A reliable and more sensitive 
quantitation is obtained by using deuterated standard (AOZ-d4) as internal standard 
(IS). The “in-house” validation of this method has been performed taking into account 
the Commission Decision 2002/657/EC. The performance characteristics of the method 
were established by in-house validation procedures employing assays with sample 
blanks, matrix-match standards (spiked with AOZ or 2-NPAOZ, with AOZ-d4). Analyte 
specificity, molecular identification (including RRT, identification points, S/N ratios, and 
transition ion ratios), linearity, extraction recovery, precision (including repeatability, 
 xix 
and within-laboratory reproducibility), and analytical limits (including LOD, LOQ, CC", 
and CC#) were validated. The fitness for purpose of this method was assessed based 
on its performance characteristics. The analytical limits obtained for all the three type of 
tiger prawn matrices were below the MRPL for nitrofuran, which is 1 ng/g. Linear 
standard curves were obtained in the ranges 0–2,000 ng/g for all types of tiger prawn 
matrices. Results showed that after furazolidone treatment, via bath treatment, of 10 
mg furazolidone/L salt water for 10 consecutive days, AOZ residue in tail muscle, head, 
and exoskeleton reached its maximum, 8,671.08 ± 628.80 ng/g, 9820.14 ± 4,15.47 
ng/g, and 11,025.12 ± 730.76 ng/g, respectively, right after stopping treatment. AOZ 
was very difficult to eliminate in vivo, thus AOZ is still detectable even after 2 month 
from the last furazolidone treatment. Three types of prawn product were selected, 
which are frozen peeled, deveined, headless prawn, frozen peeled, deveined, cooked, 
headless prawn, and marinated prawn. None of the processing methods used were 
able to eliminate all the AOZ residues in the incurred tiger prawns, with the most 
reduction, slightly less than 50 %, was observed in the incurred tiger prawns 
undergoing pre-processing coupled with frozen peeled, deveined headless cooked 
tiger prawn processing (utilising 1 % lactic acid dipping).  
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CHAPTER ONE 
INTRODUCTION and OBJECTIVES 
 
 
1.1 Introduction 
 
Drugs such as antibiotics, antimicrobials, and growth hormones have been 
developed and used to help veterinarian and the food animal producer to prevent and 
also cure diseases. It has been administered in relatively large dosages to treat sick 
animals and in lower dosages to prevent diseases in exposed animals. Bacterial 
disease of penaeid prawns can be caused by agents such as Vibrio spp., Beneckea 
sp., Flavobacterium spp., Aeromonas spp., Filamentous bacteria (Leucothrix sp.). All 
life stages of penaeid prawn are susceptible to bacterial infection and this is stimulated 
through the exposure of penaeid prawns to severe stress. 
 
The nitrofurans are synthetic antimicrobial compounds, containing in their 
molecules a characteristic 5-nitrofuran ring. Examples of nitrofurans that have been 
widely used are furazolidone, nitrofurazone, furaltadone, and nitrofurantoin (Leitner et 
al., 2001). These compounds are antibacterial drugs and are often added to feed to 
stimulate growth and to prevent and control several bacterial and protozoan infections, 
such as fowl cholera and coccidiosis black-heads (Pereira et al., 2004). These 
antibiotics are very effective drugs and do not appreciably contribute to the 
development of resistance.  
 
In contrast to the short half-life of the parent compounds, their metabolites 
persist for longer periods linked to proteins. Leitner et al., (2001) reported that 
furazolidone (parent compound) residues disappear from tissues after 12 h of 
withdrawal while it is metabolite, 3-amino-2-oxazolidinone has a half-life time between 
4 and 9 days. Thus, illegal use of nitrofuran can be monitored most effectively by 
determining the presence of bound residues (Pereira et al., 2004). 
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Controversy regarding the use of nitrofurans in food-producing animals such as 
swine, cattle, poultry, prawn, and fish has arisen during the last two decades because 
indications have appeared that residues of the drugs exhibited carcinogenic and 
genotoxic properties (McCracken and Kennedy, 1997). As a result, systemic use of all 
nitrofurans, as a chemical class, in food-producing animals was prohibited with effect 
from 1 January 1997 in the United States and EU (Leitner et al., 2001).  
 
Even though the use of nitrofurans has been prohibited in food producing 
animals, farmers are still using it illegally. Farmers from countries like Vietnam, 
Bangladesh, China, Indonesia, and Thailand were believed to be still using this 
antibiotic (Johnston and Santillo, 2002). Although farmers have been practicing the 
withdrawal period during harvesting of tiger prawns (Penaeus monodon), however, 
these have not been so successful and this antibiotic is still traceable in the end 
product. That is the reason why tiger prawns imported from these countries were 
inspected thoroughly for the trace presence of nitrofuran. For our country, Malaysia, the 
EU authorities did random testing on tiger prawns imported into EU countries.  
 
Malaysia Health Ministry is still finding residues of nitrofuran during samplings 
of food-producing animals. From the routine monitoring of nitrofuran carried out 
between 1999 and 2001, the percentage of samples found positive was 3.5 % in 1999, 
1.5 % in 2000, and 0.09 % in 2001 (Masindian, 2006). In March 2002, health 
authorities in Europe found nitrofuran residues in chicken meat imported from Thailand 
(Delforge, 2004). People’s Daily Online (2006) reported the presence of nitrofuran in 
turbot. The Daily Star (2006) also reported incidence of illegal usage of nitrofuran in 
shrimps imported to EU from Bangladesh.  
 
By looking back at statistics and reports from government agencies and 
websites, the usage of this type of veterinary drug is still going on even though it is a 
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banned veterinary drug in food-producing animal ever since June 1995 due to 
concerns regarding to their carcinogenicity and mutagenicity. Since the law could not 
eliminate the usage of these types of drugs, alternative methods are needed to assure 
that the health of consumers is not at stake. 
 
Even though chemical usage is widespread in the aquaculture industry, and the 
generic chemicals in use are known, accurate statistics on usage are hard to come by. 
While the microbiological quality of tiger prawn is closely monitored, chemical residues 
have received little attention (Johnston and Santillo, 2002). Chemical residues must be 
treated as important as microbiological quality of tiger prawn traded worldwide. That is 
why monitoring is important and need to be implemented so that all our export products 
must be free from nitrofurans or any other banned veterinary medicines. The economy 
of our country might be affected if monitoring is being ignored.  
 
Recent studies by Reed et al., (2004) on the dosing and sampling technique will 
be used as the guideline in the determination of true disposition characteristics of 3-
amino-2-oxazolidinone in tiger prawns. Numerous studies on the determination of the 
metabolites of nitrofuran antibiotics in animal tissues by high-performance liquid 
chromatography-tandem mass spectrometry (Conneely et al., 2003; Leitner et al., 
2001; McCracken and Kennedy, 1997) results in development of analytical methods for 
identification of nitrofuran metabolites. This shows the importance and need of 
monitoring the trace presence of nitrofuran metabolite derivatives in food producing 
animals. 
 
Greater and more understanding on the behaviour and the disposition of AOZ 
residue in tiger prawn can be learnt and this will benefit the next generations. This 
research can be the stepping-stone for those who have the interest in this research 
area, as there are still quite a number of drugs that can be investigated. Besides the 
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existing drugs, with the ever-growing science and technology, new drugs are emerging 
every now and then. These new drugs certainly need to undergo similar if not exactly 
the same pathway to ensure the degree of safeness when used in food-producing 
animals. 
 
1.2 Objectives 
 
The method used to analyse AOZ residue using LC-MS/MS was previously 
developed by USM Doping Control Centre (Leitner et al., 2001; Conneely et al., 
2003; O’Keeffe et al., 2004), but with some modifications are aimed at shortening the 
analytical time. Validation on the method was performed based on the guidelines set in 
CD 2002/657/EC (2002). Determination of disposition of AOZ residue in tiger prawn 
was performed using tiger prawns that were treated with furazolidone. The results 
obtained from this finding will be used on the next objective of this study, which is to 
study the effectiveness of prawn processing in eliminating AOZ residue. In general, the 
processing regimes involve peeling, deveining, beheading, washing, lactic acid dipping 
treatment, cooking, marination, and freezing. The trace presence of AOZ residue will 
be monitored in the tiger prawns while undergoing these processing regimes. Thus, 
this study will reveal any leaching or draining or breakdown of AOZ residue from the 
process that will help in reducing this residue from tiger prawns before consumption. 
 
In summary, the objectives of this study are: 
1. To validate the method used to measure the trace presence of AOZ residue 
using LC-MS/MS based on the guidelines set in CD 2002/657/EC (2002). 
2. To determine the disposition of AOZ residue in tiger prawn (Penaeus 
monodon).  
3. To monitor the effectiveness of different processing regimes in eliminating the 
trace presence of AOZ residue in tiger prawn and its products. 
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CHAPTER TWO 
LITERATURE REVIEWS 
 
 
2.1 Penaeus monodon 
 
Named for its huge size and banded tail, Penaeus monodon (common name 
include giant tiger prawn, black tiger prawn, leader prawn, sugpo, and grass prawn) still 
accounts for most of the farmed prawn coming out of Asia. Native to the Indian Ocean 
and the southwestern Pacific Ocean from Japan to Australia, tiger prawn is the world 
largest (maximum length approximately 360 mm and weigh up to 650 g) and fastest 
growing of the farmed prawn. Tiger prawn is very susceptible to two of the most lethal 
prawn viruses: yellowhead and whitespot (Kontara, 1988). 
 
The scientific classification for tiger prawn is as below (De Bruin, 1995): 
Kingdom = Animalia 
Phylum = Anthropoda 
Subphylum = Crustacea 
Class = Malacostraca 
Order = Decapoda 
Suborder = Dendrobranchiata 
Family = Penaeidae 
Genus = Penaeus 
Species = monodon 
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Figure 2.1: External anatomy of a tiger prawn.  
Source: De Bruin (1995) 
  
Tiger prawn is the most widely cultured prawn species in the world, although it 
is gradually losing ground to the Litopenaeus vannamei (common name: western white 
shrimp). Farmers throughout Asia are switching to vannamei, and it has now become 
the dominant species around the world. In 2006, tiger prawn and western white shrimp 
probably accounted for approximately 85 % of the shrimp produced on farms around 
the world (Rosenberry, 2006).  
 
  
 
Figure 2.2: The life cycle of Panaeid prawn  
Source: Lankester et al. (2003) 
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2.1.1 Prawn Culture 
 
The most important consideration in prawn cultivation is the water quality. 
Water quality should be conducive to good growth of the prawn. Some of the essential 
qualities of pond water includes temperature, salinity, dissolved oxygen, pH, nitrogen, 
phosphorous and potassium which enhance the growth of algae which serve as food. 
Hydrogen sulfide also affects the growth of prawns. Parameters for all the qualities are 
described as follows (Kontara, 1988): 
 
1) Temperature: The rate of growth increases with temperature, however, higher 
temperature causes mortality. Temperatures between 26°C to 30°C are 
considered best in terms of maximum production. Temperature above 32°C 
should be cause of concern. 
2) Salinity: Young prawns can tolerate wide range of salinity. However, very little 
is known of the salinity tolerance of sub-adult and adult prawn. Growth was 
good within the range from 20 to 30 ppt. 
3) Dissolved Oxygen: Growth is best at dissolved oxygen level above 3 ppm. 
Oxygenation of pond water is provided by the use of aeration devices and 
frequent water exchange. 
4) Water pH: Desirable pH is above 7 to 8.5. In water with pH of 6.4 and less, 
growth was reduced. When pH fell below 5.0, heavy mortalities occurred. 
5) Nitrogen compounds: There are three forms of nitrogen namely; nitrate, nitrite 
and ammonia. The concentration range of these nitrogen compounds which can 
be tolerated by P. monodon are: 
Un-ionized ammonia (NH3) - 0.0 – 1.0 mg/L 
Ionized ammonia (NH4
+
) - 0.0 – 0.5 mg/L 
Nitrite (NO2)   - 0.0 – 6.0 mg/L 
Nitrate (NO3)   - 0.0 – 200 mg/L 
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6) Hydrogen sulfide (H2S): Hydrogen sulfide (H2S) in the pond is the result of the 
chemical reduction of organic matter, which accumulates on or in the pond 
bottom. The accumulation of H2S could be avoided by periodic drying of the 
pond bottom and cultivation of the pond soil to expose the same under the sun 
until it hardens and cracks to dryness. 
 
Water temperature and salinity are measured daily at 0800 and 1700 while other 
parameters are measured every seventh day. 
 
Based on type of management, the stocking rates for tiger prawn are as follows: 
traditional method, less than 2.0/m
2
; semi-intensive, 2–4/m
2
; and for intensive, more 
than 10/m
2
. Tiger prawns are fed either twice, thrice or four times a day. The rate of 
feeding ranges from 5 to 10 % of the biomass (Kontara, 1988).  
 
2.2 Processing 
 
2.2.1 Beheading 
 
The head (cephalothorax) of fresh prawn contains organs rich in various 
digestive enzymes, which could lead to rapid deterioration of the flesh in the tail 
segment. Manual beheading is done by squeezing the prawn ahead of the tail section 
between the thumb and the fingers. Manual beheading contributes to cost saving, 
higher efficiency, and higher yields (Kanduri and Eckhardt, 2002). 
 
 
2.2.2 Peeling and Deveining 
 
The vein is the prawn intestine that runs down the dorsal side near the surface. 
It is usually filled with food and sand; its removal improves product quality (Kanduri and 
Eckhardt, 2002). 
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2.2.3 Additive Dipping 
 
Okolocha and Ellerbroek (2005) mentioned that with the right modification and 
acceptable concentrations of acids and/or alkalis, additive dipping can give a good 
reduction on the populations of bacteria and increase the shelf life of meat products. 
Several researches have focused on additive treatment on ground beef (Jimenez-
Villarreal et al., 2003), chilled beef carcasses (Gill and Badoni, 2004) and poultry meat 
(Okolocha and Ellerbroek, 2005). Jimenez-Villarreal et al. (2003) listed some of the 
common additives used, which are chlorine dioxide, cetylpyridinium chloride, organic 
acids, and trisodium phosphate.    
 
Cassens (1994) mentioned that the usage of 1 – 2% of lactic acid in carcass 
rinses, as a means to control microbiological contamination, is effective without causing 
colour or flavour problems.  
 
2.2.4 Cooking 
 
Erdo!du et al. (2001) listed two changes during thermal processing of prawns, 
which are denaturation of proteins and also reduction on water holding ability. These 
two changes lead to yield loss and dimensional changes. Reduction in microbial load is 
an important factor in processing with proper cooking schedules (Erdo!du et al., 2003). 
Due to its higher resistance compared to other microorganisms, Vibrio cholera (D65 = 
93s, z = 7.7°C) was chosen as the target organism in safety hazards in seafood 
products (Rippen and Hackney, 1992).  
 
 Erdo!du et al. (2003) reported that long cooking times and/or high cooking 
temperatures contribute to better product safety and speed but with the price of higher 
yield loss and also lower sensory quality. As a result, they produce two separate 
 10 
cooking charts, one for large tiger prawn (35 to 44 prawns/kg) (Figure 2.3) and another 
one for medium tiger prawn (90-110 prawns/kg) (Figure 2.4). 
 
Figure 2.3: The constructed cooking chart for large tiger prawn (35 - 44 prawns/kg). 
Source: Erdo!du et al. (2003) 
 
 
Figure 2.4: The constructed cooking chart for medium tiger prawn (90 - 110 
prawns/kg).  
Source: Erdo!du et al. (2003) 
 
2.2.5 Marinating 
 
The word “marinate” originated from the Latin word “marine” to Italian, Spanish, 
and French languages with the meaning of soaking/pickling in salt brine. According to 
Cadun et al. (2005), marinated prawns are widely consumed in European countries 
and America. Formulations for marinades include sugar, spices, oil, acids (such as fruit 
juice, vinegar, and wine) (Zheng et al., 1998), rheology-improving additives (such as 
guar gum, and xanthan), antimicrobial agents (such as benzoate, and sorbate), and 
aroma enhancers (Björkroth, 2005).  
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Besides improving taste (tenderness, juiciness, flavour, and aroma), marinating 
also acts as a preservation method by preventing the growth of pathogenic bacteria 
and most spoilage bacteria. The ability to suppress microbial growth is due to the high 
acidity (low pH value, not higher than 4.8) since most of the food poisoning and 
spoilage bacteria are inhibited at pH lower than 4.8. Thus, increasing the shelf life and 
safety of the marinated products (Kilinc and Cakli, 2004; Björkroth, 2005; Cadun et al., 
2005).    
 
Acceptability of marinated prawns must also be based on sensory analysis 
besides low bacterial counts. Cadun et al. (2005) reported that pink prawns 
(Parapenaeus longirostris) marinated for 40 days have low bacterial count, but due to 
high rancidity or fat oxidation, the sensory score shows low acceptability by sensory 
panelists.     
 
2.2.6 Freezing 
 
Jaacobsen and Fossan (2001) mentioned that the quality of prawn is altered 
during frozen storage particularly by oxidation, proteins denaturation, sublimation, and 
recrystallisation of ice crystals. Both the oxidation and sublimation processes during 
frozen storage are the main culprits behind the formation of bad aroma, yield loss, 
rancidity, and toughening of the meat in frozen prawns. 
 
2.2.7 Glazing 
 
For ages, ice-glazing has been a well-known method to prevent dehydration 
and oxidation in frozen products during long-term storage, in which both deteriorations 
will lead to changes in colour, odour, and texture of the frozen products (Jaacobsen 
and Fossan, 2001). Mathen et al. (1970) listed 2 glazing methods, which were dipping 
and spraying the frozen products with glazing water at temperature below 1°C 
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(Mohamed Hatha et al., 1970) before rapidly refrozen. At times, salt-sugar solutions are 
also used to substitute glazing water. Rapid refreezing is an important step as this will 
preserve the overall consumer acceptability, in terms of taste, smell, and texture as 
well as to minimize thaw drip loss (Jose and Sherief, 1993).     
 
2.3 Veterinary Medicines 
 
Veterinary medicine is defined as any substance or combination thereof 
presented for its ability to treat or prevent disease in animals or which may be 
administrated to animals with the aim of medical diagnosis or restoring, correcting or 
modifying physiological functions in animals (McEvoy, 2002).  
 
It is commercially available in two form, either in its original form or mixed with 
animal feed, which is known as medicated feeding stuffs. McEvoy (2002) termed 
medicated feeding stuffs as any mixture of a veterinary medical product(s) and feed(s), 
which is ready prepared for marketing and readily used to feed animals without any 
further alteration to it, because of its curative or preventive properties or other 
properties as a medicinal product. 
 
2.3.1 Antibiotic 
 
The term ‘antibiotic’ is normally reserved for a very diverse range of both natural 
and semi-synthetic low molecular weight compound, which possess antibacterial 
activity. Strictly speaking, penicillins, tetracyclines, macrolides, aminoglycosides, and 
amphenoicols are antibiotics while sulfonamides, nitroimidazoles, nitrofurans, and 
quinolones are not. Rather, they are antibacterials because of being synthetic 
(Kennedy et al., 1998; Di Corcia and Nazzari, 2002). Gentili et al. (2005) also stated 
that natural substances at high molecular weight, such as polyether antibiotics are also 
considered as antibacterials. 
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2.3.2 Antimicrobial 
 
Antimicrobial drugs are synthetic compound, which possess antibacterial 
activity (Kennedy et al., 1998; Di Corcia and Nazzari, 2002). These types of veterinary 
drug are used in food producing animals for a wide range of purpose. Besides having 
the therapeutic effects against disease agents, it is responsible for changes in the 
structure or function of systems (or maybe both) within the target animal (Yan and 
Gilbert, 2004). 
 
2.4 Methods of Drug Delivery 
 
Dosage and time treatment are some of the important parameters to achieve 
desirable result. Dosage level or treatment time that exceeds the normal threshold 
might lead to danger of toxicity to the animals. On the other hand, if the dosage level or 
treatment time is too low, the bacteria will survive and will contribute a great portion to 
the possibility of the bacteria developing resistance to the veterinary drug (Yanong, 
2003).   
 
Yan and Gilbert (2004) listed the three main methods of veterinary drug delivery 
in food producing animals, which are parenteral administration, oral administration and 
intrauterine infusion. In addition, Yanong (2003) listed another major route of 
administration, which is bath treatment. The criteria for choosing which method to be 
used are based on the animal species, the infectious disease target, the drug 
formulation or purpose for which the antimicrobials are employed. 
 
2.4.1 Oral Administration 
 
Oral administration is a convenient method due to the easiness to administer 
the drugs to the animals (Yan and Gilbert, 2004) and is commonly used in aquaculture 
production due to the cost effectiveness (Yanong, 2003). Normally, antimicrobials 
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(including nitrofuran) are administered with this method either mixed with animal feeds 
(using fish oil or canola oil as a binding agent) or drinking water (Díaz et al. 1997; 
McEvoy, 2002; Yanong, 2003).  
 
The bioavailability of particular drug is dependent on the degree of absorption of 
the drug itself, and the conditions of the gastrointestinal luminal environment (e.g., pH, 
ionic tension, food material interference, etc) (Yan and Gilbert, 2004). Plakas et al. 
(1994) reported that the oral bioavailability of furazolidone administered in solution was 
58%, compared with 28% in a feed mixture. Yan and Gilbert (2004) reported that 
drinking water medication is better compared to feed medication because diseased 
animals generally continue to consume fluids even after they have stopped eating.  
 
2.4.2 Parental Administration 
 
Parenteral administration is normally the choice after failure of oral 
administration to deliver an adequate dose of the veterinary drug presented in feed or 
water. The failure of oral administration is normally due to the failure of sick animal to 
intake any veterinary rug orally (Yan and Gilbert, 2004). The two most common 
parenteral routes of administration are intramuscular or subcutaneous administrations.  
 
Reed et al. (2004) used intrasinus dosing on the white prawn, Litopenaeus 
setiferus to study the pharmacokinetics of oxytetracycline. Oxytetracycline doses were 
delivered through the arthrodial membrane at the junction of the carapace and 
abdomen on the ventral side into the ventral intrasinus space of the prawn. 
 
2.4.3 Intrauterine Infusion 
 
Intrauterine infusion is a type of veterinary drug administration that is organ- 
specific drug delivery method. This type of delivery method allows a relatively high 
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concentration of drug at the infected site compared to other part of the animal. 
Generally, antimicrobial drugs delivered via these routes have less impact on the gut 
microflora due to the low concentration of drug in the gastrointestinal.  (Yan and 
Gilbert, 2004).    
 
2.4.4 Bath Treatment 
 
Yanong (2003) mentioned that bath treatment is a popular route of antibiotics 
administration even though it required much more drug when compared to other routes 
to achieve the desired results. In order to achieve the most effective result when using 
furazolidone, using cover or finding a suitable treatment location is important due the 
susceptibility of furazolidone to deterioration by light.  
 
2.5 Withdrawal Period 
 
Withdrawal period refers to the appropriate time interval starting from the day of 
the last administration of the veterinary drug under normal conditions of use until the 
day when the treated animals is considered safe to be slaughtered for the production of 
safe food products. Withdrawal period is important because it should archive the 
ultimate goal of having the concentration of residues in food derived from these treated 
animals not exceeding the maximum residue limits (MRLs) with high degree of 
assurance (Díaz et al. 1997; Anadón and Martínez-Larrañaga, 1999; Vranic et al., 
2002). 
 
Vranic et al. (2002) listed the three main methods for estimation of the 
withdrawal period for veterinary drugs used in food producing animals, which are 
Decision Rule, Linear Regression, and Non-parametric Approach. All these three 
methods have the same ultimate goal. But, there is a slight difference between these 
three methods, and that is the length of the interval period. Vranic et al. (2002) reported 
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that the estimated withdrawal period by the method of Linear Regression is the 
shortest, while the longest is by the method of Non-parametric Approach.  
 
Hoogenboom et al. (1991) and (1992) reported that the withdrawal period for 
medicated animals with furazolidone is long. AOZ was still detectable in liver, kidney 
and muscles of furazolidone treated pigs (300mg furazolidone per kg of feed for a 
period of 7 days) at a concentration of 41, 7 and 10ng/g respectively even after 4 
weeks from the day of the last medication. Conneely et al. (2002) reported that the 
metabolite can still be detected in the tissues of furazolidone treated animal for up to 
seven weeks after withdrawal of furazolidone. 
 
2.6 Furazolidone 
 
In 1944, Dood and Stillman discovered for the very first time that by adding a 
single nitro group in C5 of the furan ring, it gave rise to a molecule with bacteriostatic 
properties. Thus, nitrofurans were developed. With the correct modification on C2 of 
the furan rings, different types of nitrofurans were generated. The inclusion of a 
conjugated carbon – carbon or carbon – nitrogen double bond between the nitrofuril 
group and the terminal portion of the lateral chain in C2 will enhance the antibacterial 
activity.    (Monasterios et al., 2005). Among them there are four of the most prominent 
nitrofurans, which are furazolidone, nitrofurantoin, nitrofurazone, and furaltadone 
(Mottier et al., 2005).  
 
N-(5-nitro-2-furfurylidene-3-amino)-2-oxazolidinone or commonly known as 
furazolidone (fyoor-a-ZOE-li-done) is a synthetic chemotherapeutic agent that belongs 
to the class of 5-nitrofurans (Draisci et al., 1997; McCracken and Kennedy, 1997a; 
Kennedy et al., 1998; Cooper et al., 2004). Furazolidone occurs as a yellow odorless 
crystalline powder with a bitter aftertaste. It is practically insoluble in water and alcohol. 
The presence of alkali will decompose furazolidone. Exposure to daylight for 6 h will 
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cause nearly total (around 93%) decomposition of the furazolidone but was unchanged 
when exposed to fluorescent light in the same time period (Muth et al., 1996). Thus it 
should be stored in light resistant containers.   
 
The presence of a 5-nitro group enables furazolidone to have a broad spectrum 
of activity and for this reason it is widely used as veterinary drugs (Draisci et al., 1997; 
Kennedy et al., 1998; Balizs and Hewitt, 2003; Auro et al., 2004). Monasterios et al. 
(2005) mentioned that furazolidone is useful in the treatment of invasive bacterial 
diarrhea and parasitic condition due to its low absorption through the intestine. 
Furazolidone is predominantly bacteriostatic. But at high doses, it acts as bactericidal 
(Kennedy et al., 1998). The ability to act as bactericidal is due to its ability to interfere 
with several bacterial enzyme systems, possibly including prevention of acetylation of 
coenzyme A and also acts as a monoamine oxidase (MAO) inhibitor (Hoogenboom, 
1991; Di Corcia and Nazzari, 2002; Balizs and Hewitt, 2003; Cash and Johnston, 
2004).  
 
2.6.1 Furazolidone as Veterinary Medicine 
 
Since 1953 (before furazolidone was banned), it was used for treatment in 
turkeys and chickens of fowl typhoid, paratyphoid, and pullorum; blackhead 
(histomoniasis); nonspecific enteritis (blue comb, mud fever), ulcerative enteritis (quail 
disease), and synovitis (arthritis due to filterable virus); and paracolon infection 
(Paracolobactrum). In chicken its use for infectious hepatitis and coccidiosis. While in 
turkeys its use for hexamitiasis, and in swine for bacterial enteritis (nercotic enteritis, 
necro, black scours) or vibrionic (bloody) dysentery (Bryan, 1978). 
 
Normally, antibacterial drugs including furazolidone at therapeutic dose are 
administrated orally or mixed with animal feed as food additive (Draisci et al., 1997). 
Furazolidone is widely used as food additives for the treatment of gastrointestinal 
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infections caused by Escherichia coli and Salmonella spp in cattle, swine, fish, prawns, 
and poultry (Hartig et al., 2003; Gao et al., 2003; Cooper et al., 2004; Finzi et al., 2005; 
Szilagyi and de la Calle, 2006). Furazolidone is also given to prevent and control 
several bacterial and protozoan infections. For example, fowl cholera, coccidiosis 
blackheads and swine enteritis in poultry and pigs and mastitis in dairy cattle (Draisci et 
al., 1997; Auro et al., 2004). 
 
Doses lower than the usual therapeutic level are administrated to promote 
weight gain, for feed conversion (McCracken and Kennedy, 1997a; Cooper et al., 
2004), to prevent disease, and to increase feed efficiency (Bryan, 1978), thus 
increasing the meat yield per pound of feed used as well as for maintaining adequate 
growth rate, feed conversion (McCracken and Kennedy, 1997a; Cooper et al., 2004) 
and enhanced feed efficiency (Bryan, 1978). 
 
2.6.2 Furazolidone as Human Medicine 
 
Furazolidone is also used to treat human as a medicine. Furazolidone has been 
used for the treatment of bacillary dysentery, typhoid and paratyphoid fevers, giardiasis 
(caused by protozoan Giardia lamblia), brucellosis, and intestinal infections of 
undetermined etiology (Bryan, 1978; Díaz et al., 1997). It is also used in the treatment 
of trichomoniasis, giardiasis (for adult, dosage of furazolidone is 100mg, four times 
daily for seven to ten days), cholera (for adult, dosage of furazolidone is 100mg, four 
times daily for four to seven days), and other vibrio infections. Besides that, 
furazolidone has been reported to possess anti-Helicobacter activity and to have some 
ulcer-healing properties (Monasterios et al., 2005).  
 
Backer (2000) mentioned that furazolidone is used commonly in treating 
children who suffered from giardiasis because it is available in a liquid suspension and 
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is well tolerated. Cash and Johnston (2004) mentioned that furazolidone is the 
antibiotic of choice in pregnant individuals in treating giardiasis.  
 
Furazolidone also holds a particular advantage in treating cholera over other 
antibiotics, including tetracycline, in that several antibiotic-resistant strains are 
susceptible to it in vitro (Glass et al., 1980). Rabbani et al. (1991) added that 
furazolidone, given as either a single dose (7mg/kg/day) or a dose of 7mg/kg/day 
divided in four equally daily doses for 3 days, is effective treatment for childhood 
cholera. Furazolidone also seems to be more effective compared to ampicillin in 
therapy for acute traveler’s diarrhea. The mean duration of diarrhea was shortened on 
the average from 72 to 57 h for all cases irrespective of entiology (DuPont et al., 1984) 
 
2.6.3 Furazolidone Metabolism 
 
Furazolidone has an in-vivo half-life of only a few hours (Hartig et al., 2003), 
whilst Cooper et al. (2004) confirmed that furazolidone disappeared from tissue within 
12 h of withdrawal. Elimination of furazolidone in channel catfish was also extremely 
rapid, with a terminal half-life of 0.27 h and total body clearance of 1901 mL/h/kg 
(Plakas et al., 1994). McCracken and Kennedy (1997a) reported that the concentration 
of furazolidone found in kidney and liver of furazolidone treated porcine, fell below 5 
ng/g within 4 and 6 h, respectively. Due to this very instability or rapid metabolism 
property of furazolidone and its incapability to persist in edible tissue, analysis of intact 
furazolidone in tissues is both difficult and of limited value. For this reason, it has in the 
past prevented the detection of this veterinary drug in food producing animals 
(McCracken and Kennedy, 1997a; Conneely, et al., 2002; Hartig et al., 2003; Xu et al., 
2006). However Tatsumi et al., (1984) successfully isolated N-(4-carboxy-2-
oxobutylideneamino)-2-oxazolidone, "-ketoglutaric acid, 3-(4-cyano-2-
oxobutylideneamino)-2-oxazolidone, and N-(5-acetamido-2-furfurylidene)-3-amino-2-
oxazolidone from the urine of rats treated orally with furazolidone. 
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Metabolism of furazolidone gives rise to different forms of extractable and 
protein-bound residues (O’Keeffe et al., 1999). The major metabolite from the use of 
furazolidone in mammals, birds and fish is 3-amino-2-oxazolidinone (AOZ) while the 
minor metabolite is N-(5-amine-2-furfuryliden)-3-amine-2-oxazolidinone (FOZ) (Auro et 
al., 2004). These metabolites are covalently bound to cellular protein in vitro (Draisci et 
al., 1997; Di Corcia and Nazzari, 2002). AOZ has a higher stability and longer 
residence time (between 4 and 9 days half life time and are detectable for up to 7 
weeks after administration) when compared to the parent drug (Leitner et al., 2001; 
Conneely et al., 2002; Yang, 2003).  
 
2.6.4 Furazolidone Toxicity 
 
Concerning the toxicology properties of nitrofurans, mutagenic activity has been 
observed and reported in research using yeasts, fungi, bacteria and sub-mammalian 
systems. In addition, researches using rats and mice have shown that nitrofurans are 
tumorigenic. Besides that, nitrofurans have been shown to be cyctoxic to mammalian 
cells in culture. The tumorigenic and cyctoxic effects seem to be related to the 
nitrofurans compound itself and also to the metabolite formation (Draisci et al., 1997). 
For furazolidone, it has been suggested that its metabolite, AOZ can be metabolized 
into #-hydroxyethylhydrazine, which is a mutagenic and carcinogenic compound 
(O’Keeffe et al., 1999).  
 
Díaz et al. (1997) mentioned that even though the toxic effects (also mutagenic 
and carcinogenic) of most of the nitrofuran are well documented, their precise mode of 
action is not fully clarified (and neither is their fate). Therefore, further and advance 
research on the mode of action must be carried out in order to affirm the toxicity of 
furazolidone and its metabolites.  
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2.6.5 Contradiction for Furazolidone Toxicology 
 
Cancer induction was established using laboratory animals that were treated 
directly with large quantities of nitrofuran. Human as we know, show no danger sign 
when nitrofuran is consumed. That is why it is still being used in treating giardiasis and 
cholera. Rather, humans are in danger of consuming the residues of the main 
nitrofuran metabolites, AOZ and a minor metabolite, FOZ. But, up to this date, 
evidence that AOZ/FOZ can induce genotoxic or carcinogenic effect remains 
inconclusive (Auro et al., 2004).  
 
Auro et al. (2004) reported that both tilapias (Oreochromis niloticus) fed with 
tilapia-meal (feed made from tilapia) contaminated with AOZ/FOZ and mollies (Poecilia 
Formosa) fed with mollie-meal (feed made from mollie) meal contaminated with 
AOZ/FOZ, both at concentration of 500g of fishmeal/kg of furazolidone-free commercial 
feed, show no sign of developed tumours. These results do not support the established 
viewpoint that furazolidone must be banned from tropic chains based on its potential 
carcinogenic properties. 
 
Klee et al. (1999) reported that no acute toxicity of AOZ or digested food 
residues in gut segments at Caco-2 cells at concentration that were substantially above 
the maximum residue levels to be expected in the food of animal origin after 
administration of therapeutic doses. The inability to find acute toxicity in gut at Caco-2 
cells is due to the extensive metabolism and detoxification of furazolidone by 
glutathione (De Angelis et al., 1999). The results demonstrate that the chemical nature 
of drug residues can be altered by digestive process. In addition, this process may also 
yield degradation products that may be bioavailable for the consumer. Thus, the 
covalently bound xenobiotics at macromolecular tissue cannot necessarily be regarded 
as an irreversible endpoint of residue bioavailability and toxicity (Klee et al., 1999). 
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2.6.6 Source of Furazolidone Contamination 
 
Trace amount of nitrofuran contamination has been detected in warm-water 
prawns, prawn, and chicken (Yang, 2003). It has been reported that there are 
numerous ways for the contamination to occur. Contamination may occur from 
deliberate, direct misuse of the drugs, as well as from contaminated feed, or 
environment sources (Leitner et al., 2001; Gao, 2003; Yang, 2003; Pereira et al., 
2004). Furthermore, contamination may also occur from transfer between animals via 
ingestion of faeces and/or urine (Kennedy et al., 2000; Leitner et al., 2001). Kennedy et 
al. (2000) and McEvoy (2002) reported that contamination of feeds is linked to human 
error, improper cleaning, carried over of contamination from medicated feeds to 
subsequent batch (unmedicated feeds), production practices and handling procedures 
in the feed mill, during transport and on farm.  
 
McCracken et al. (2000) successfully setup a criterion that makes the 
differentiation between furazolidone abuse and contamination possible. Porcine treated 
with furazolidone illegally will have a concentration ratio of AOZ in bile:kidney of less 
than 0.3; while unmedicated porcine contaminated with AOZ will have concentration 
ratio of AOZ in bile:kidney of greater than 3.0. 
 
2.6.7 Current Issues on Furazolidone Contamination 
 
The presence of nitrofurans in food producing animals are undeniable even 
after the implementation of regulation against the use of nitrofurans in the mid 90’s. A 
survey was done to investigate the occurrence of furazolidone residues in pigs from 
Northern Ireland between February 1995 and July 1995. Out of one hundred samples, 
seventeen percent of the samples were found positive (McCracken and Kennedy, 
1997a). In 2002 nitrofurans and their metabolites were frequently detected in imported 
poultry from Brazil and Asia, and prawns from Asia (Johnston and Santillo, 2002; 
 23 
McEvoy, 2002; Hartig et al., 2003). The detected concentrations varied as high as 
320ppb and as low as 0.6ppb (Hartig et al., 2003). Conneely et al., (2003) have also 
reported that residues of nitrofuran drugs have been detected in poultry and shellfish 
imported into the EU. 
 
2.7 AOZ (Furazolidone Metabolite) 
 
Covalently bound residues are derived from the covalent binding of the parent 
drugs or its metabolites to endogenous macromolecules. These covalently bound 
residues are not readily extractable from the tissues by mild aqueous or organic solvent 
extraction, denaturation, and solubilisation techniques (Burgat-Sacaze and Rico, 1990). 
Mostly, to breakdown this type of binding, more extensive and rigorous chemical 
treatments are required, such as treatment with acid, base, or enzymes (O’Keeffe et 
al., 1999). 
 
Covalently bound residues play an important role in food safety since it possess 
high stability to remain intact within the macromolecules for a long period of time after 
the withdrawal of the drug treatment. In addition, the ability of the binding to breakdown 
during digestion to release a compound that is in biologically active forms also 
contributes to the importance in food safety (O’Keeffe et al., 1999). 
 
Each nitrofurans have its own metabolites. The main metabolites that are of 
concerns in detection of furazolidone, furaltadone, nitrofurantoin, and nitrofurazone are 
AOZ, 3-amino-5-methylmorpholino-2-oxazolidinone (AMOZ), 1-aminohydantoin (AH), 
and semicarbazide (SC), respectively (Leitner et al., 2001; Edder et al., 2003; Pereira 
et al., 2003; Yang, 2003). Samuelsen et al. (1991) reported that AOZ had no detectable 
antibacterial activity.  
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Figure 2.5: Structure of the nitrofuran antimicrobials and their free major metabolites.  
Source: Leitner et al. (2001) 
 
Draisci et al., (1997) and Di Corcia and Nazzari, (2002) reported that 
furazolidone metabolite, AOZ, forms a covalent binding to cellular protein. The covalent 
bonding between AOZ and the cellular protein is called azomethine bond. These bonds 
are hydrolysable by acid hydrolysis to release AOZ molecules (Hoogenboom, 1991; 
Horne et al., 1996), subsequently cleaved to ethylene (Hunder et al., 1987). 
 
2.7.1 AOZ Residence Time in Animal Tissue 
 
Tissue-bound metabolites are formed after treatment with the parent drug, 
furazolidone (Conneely et al., 2002). It is covalently bound to cellular protein in the 
tissues, such as liver, of the treated animals (Draisci et al., 1997; O’Keeffe et al., 1999). 
Due to the presence of these covalent bonding, the rate of elimination of furazolidone 
metabolites from the animal body is dependent on the rate of turnover of tissue protein, 
